Cite
HARVARD Citation
Breccia, M. et al. (n.d.). Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib. Leukemia & lymphoma. 55 (1), pp. 204-206. [Online].